BD Biosciences and StemCell Technologies Sign License Agreements with WARF
Commercialization of Novel Culture Media and Surfaces for Human Embryonic Stem Cell Research
19-Jun-2007 -
BD Biosciences, a segment of global medical technology company BD (Becton, Dickinson and Company), and StemCell Technologies, Inc. announced that they have each entered into a worldwide license agreement with the Wisconsin Alumni Research Foundation (WARF). The agreements will allow BD ...
BD
cell cultures
embryonic stem cells
+4